CORE LABORATORIES N V Quarterly Common Stock, Shares Authorized from Q4 2010 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Core Laboratories N V quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q1 2023.
  • Core Laboratories N V Common Stock, Shares Authorized for the quarter ending March 31, 2023 was 200M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 200M 0 0% Mar 31, 2023 10-Q 2023-04-27
Q4 2022 200M 0 0% Dec 31, 2022 10-Q 2023-04-27
Q3 2022 200M 0 0% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 200M 0 0% Jun 30, 2022 10-Q 2022-07-28
Q1 2022 200M 0 0% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 200M 0 0% Dec 31, 2021 10-K 2023-02-10
Q3 2021 200M 0 0% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 200M 0 0% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 200M 0 0% Mar 31, 2021 10-Q 2021-04-23
Q4 2020 200M 0 0% Dec 31, 2020 10-K 2022-02-10
Q3 2020 200M 0 0% Sep 30, 2020 10-Q 2020-10-22
Q2 2020 200M 0 0% Jun 30, 2020 10-Q 2020-07-24
Q1 2020 200M 0 0% Mar 31, 2020 10-Q 2020-04-24
Q4 2019 200M 0 0% Dec 31, 2019 10-K 2021-02-08
Q3 2019 200M 0 0% Sep 30, 2019 10-Q 2019-10-25
Q2 2019 200M 0 0% Jun 30, 2019 10-Q 2019-07-26
Q1 2019 200M 0 0% Mar 31, 2019 10-Q 2019-04-26
Q4 2018 200M 0 0% Dec 31, 2018 10-K 2020-02-10
Q3 2018 200M 0 0% Sep 30, 2018 10-Q 2018-10-25
Q2 2018 200M 0 0% Jun 30, 2018 10-Q 2018-07-27
Q1 2018 200M 0 0% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 200M 0 0% Dec 31, 2017 10-K 2019-02-11
Q3 2017 200M 0 0% Sep 30, 2017 10-Q 2017-10-25
Q2 2017 200M 0 0% Jun 30, 2017 10-Q 2017-07-26
Q1 2017 200M 0 0% Mar 31, 2017 10-Q 2017-04-21
Q4 2016 200M 0 0% Dec 31, 2016 10-K 2018-02-12
Q3 2016 200M 0 0% Sep 30, 2016 10-Q 2016-10-21
Q2 2016 200M 0 0% Jun 30, 2016 10-Q 2016-07-22
Q1 2016 200M 0 0% Mar 31, 2016 10-Q 2016-04-22
Q4 2015 200M 0 0% Dec 31, 2015 10-K 2017-02-10
Q3 2015 200M 0 0% Sep 30, 2015 10-Q 2015-10-23
Q2 2015 200M 0 0% Jun 30, 2015 10-Q 2015-07-27
Q1 2015 200M 0 0% Mar 31, 2015 10-Q 2015-04-29
Q4 2014 200M 0 0% Dec 31, 2014 10-K 2016-02-12
Q3 2014 200M 0 0% Sep 30, 2014 10-Q 2014-11-04
Q2 2014 200M 0 0% Jun 30, 2014 10-Q 2014-07-25
Q1 2014 200M 0 0% Mar 31, 2014 10-Q 2014-04-25
Q4 2013 200M 0 0% Dec 31, 2013 10-K 2015-02-17
Q3 2013 200M 0 0% Sep 30, 2013 10-Q 2013-10-18
Q2 2013 200M 0 0% Jun 30, 2013 10-Q 2013-07-19
Q1 2013 200M 0 0% Mar 31, 2013 10-Q 2013-04-19
Q4 2012 200M 0 0% Dec 31, 2012 10-K 2014-02-13
Q3 2012 200M 0 0% Sep 30, 2012 10-Q 2012-10-19
Q2 2012 200M 0 0% Jun 30, 2012 10-Q 2012-07-20
Q1 2012 200M 0 0% Mar 31, 2012 10-Q 2012-04-23
Q4 2011 200M 0 0% Dec 31, 2011 10-K 2013-02-19
Q3 2011 200M Sep 30, 2011 10-Q 2011-10-25
Q2 2011 200M Jun 30, 2011 10-Q 2011-07-29
Q1 2011 200M Mar 31, 2011 10-Q 2011-04-22
Q4 2010 200M Dec 31, 2010 10-K 2012-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.